Skip to main content
letter
. 2023 Mar 6;73(4):706–708. doi: 10.1136/gutjnl-2023-329695

Figure 1.

Figure 1

Response to SSRD in IBS-D patients, stratified according to SI hypomorphic genotype (double-carrier, single-carrier and non-carrier groups), at 2 weeks (top) and 4 weeks (bottom). *p=0.043 for double-carriers versus other groups (one-tailed Fisher’s exact test). IBS-D, irritable bowel syndrome-diarrhoea; SI, sucrase-isomaltase; SSRD, sucrose and starch-restricted diet.